Lung Cancer News & Features
RNA test of blood platelets can detect, classify, and pinpoint the location of cancer by analyzing a sample equivalent to 1 drop of blood. Using this new method, researchers were able to identify cancer with 96% accuracy.
Human epidermal growth factor receptor 2 (HER2)-driven non-small cell lung cancers (NSCLC) are sensitive to chemotherapy.
Prophylactic minocycline and reactive treatment are both acceptable options for treatment of erlotinib-induced rash in non-small cell lung cancer (NSCLC).
Surgery be a treatment option for patients with lung cancer that were previously deemed ineligible.
The likelihood of patients with early stage non-small cell lung cancer (NSCLC) undergoing curative-intent surgery varies.
Lung Cancer Videos
Lung Cancer Clinical Trials
- Blood Test Indicates Breast Cancer Tumors Developed Resistance to Hormone Treatment
- Breakthrough Advance Announced in International Blood Cancer Drug Trial
- Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
- Yoga May Reduce Side Effects in Patients Receiving Treatment for Prostate Cancer
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- Chemo, Tamoxifen May Increase VTE Risk Among Patients With Breast Cancer
- Protein Biomarker Assays for Diagnosing Thyroid Cancer May Show Inaccurate Readings
- Cancer Prehabilitation and Rehabilitation: What Will It Take for These Services to Catch On?
- New Model for Breast Cancer Risk in Hispanic Women Is the First to be Based Exclusively on Data From Hispanic Women
- Blood Sample New Way of Detecting Cancer
- Liquid Biopsy of Cerebrospinal Fluid More Effective in Managing Brain Tumors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|